Affordable Medicines Under Attack: Examining the Skewed Lustra Review

Response to Biased Review of Lustra Cannabis Product

This recent video review of the Lustra cannabis product manufactured and sold by Oasis Cannabis selectively frames the product and omits the reviewer’s potential conflicts of interest, unfairly criticizing Lustra’s quality and value without appropriate diligence or transparency.

What the Review Claims & Overlooks

The reviewer cites apparent “impurities,” an “off-putting consistency,” and urges prospective consumers to “be cautious” regarding Lustra – a product priced $36 before taxes, below many competitors. However, the review leaves out contextual details that viewers require to properly scrutinize these statements.

No Objective Visual Comparisons

When showcasing rival brands like Goldfish and Couch Lock, the reviewer’s camera work utilizes close up lighting and angles that visually enhance aesthetic details like shine and color consistency. Yet the technique appears casually dismissive when evaluating Lustra itself – making no effort to benchmark products under similar visual conditions.

This suggests possible cinematographic bias on superficial characteristics unrelated to medical effectiveness. The selectivity visually elevates promoted brands as pristine while depicting Lustra as dull and distasteful by comparison. But more unified parameters may have shown less disparity on factors like glisten, pigment evenness, and apparent purity between products.

Unknown Handling & Storage Before Review

The review includes no description detailing how the examined Lustra sample was stored over time, who handled it, what containers or temperatures it faced, and other stability factors during the period prior to video recording.

This omission spurs unanswered questions around whether the reviewed specimen legitimately embodied the product line or stood as an outlier. Perhaps the reviewer or an associate tampered with or degraded it well before filming. With handling visibility before harsh indictment lacking, doubts arise on the judged product’s integrity when reaching the on-camera critique.

Unsubstantiated Claims versus Actual Comparisons

The reviewer backs key criticisms around smell, consistency, color, and visible impurities only through repeated glances at the sample jar. We have compiled extensive side-by-side visual comparisons between their reviewed specimen and recent Lustra inventory with robust quality control filtering intact.

IMAGES OF LUSTRA - KRYPTONITE 1G LIVE ROSIN ON 1/19/2024 TAKEN BY OASIS CANNABIS

The imagery benchmarks expose jarring contradictions against the reviewer’s sweeping claims on detected flaws in purity and texture. This pattern combined with the above issues point to an unrepresentative Lustra sample utilized to unfairly undermine the product line through distorted assertions around integrity.

IMAGES OF ALLEGED KRYPTONITE 1G LIVE ROSIN BY CRUZ HERNANDEZ AKA “STONEHEADNM”

No Revelation of Potential Conflicts of Interest

The reviewer maintains associations with unnamed Lustra market competitors and industry members while appearing to promote a specific dispensary chain within the review video itself. Yet they failed to reveal these potential entanglements or equities.

The informal endorsement of the Breaking Buds outlet accompanied recommendation of a particular branded rosin product available there at advertised discount. This juxtaposition paired with undisclosed affiliations plants doubt regarding impartiality in assessing a directly competing inexpensive product like Lustra.

While reviewers may recommend preferred brands, lacking transparency around possible related monetary ties or friendships when critiquing alternatives makes integrity difficult to confirm. Rather than an ethical buyer’s guide, the video plays more as a veiled commercial against Oasis’ affordable Lustra option to boost allies.

Affordable Cannabis Access for Improved Livelihoods

While we strive tirelessly for maximum quality assurance, Oasis Cannabis stays dedicated to keeping therapeutic products reasonably priced – particularly to service patients and consumers without abundant financial means. Availability of affordable cannabis positively impacts public health and welfare.

One’s access to healthcare solutions should never predominantly fill the pockets of detached corporations or force budgetary sacrifice on essential goods just to treat medical conditions. We openly invite any Lustra purchasers with product concerns to reach out so we can make things right.

Legal Policy Regarding Unfair Competition

Moving forward under counsel guidance, Oasis Cannabis will firmly defend the safety and integrity measures behind all in-house manufactured products like Lustra. We pride compliant operation with full testing and audits since our inception. Malicious attacks compromising public faith in affordable medicine helpful to vulnerable groups will compel harsh response.

We Welcome Customer Feedback

Oasis Cannabis stands behind our extraction methods, safety protocols, handling procedures, packaging, and storage practices to deliver the best possible value-priced Lustra product at $36 before taxes. Consumers enjoying far more budget flexibility can freely pay double, triple or even quadruple that price for competitors’ alternative offerings. But new medicinal customers with limited budgets rightfully deserve assurance in starting their health journey with us.

While some influencers may publicize friends today and pivot again tomorrow, our patient service dedication in New Mexico endures thanks to credibility measured in years – not clicks. We invite shoppers to experience our standards and value first-hand. Please come witness the difference.

Conclusion

To our knowledge, the reviewer lacked credible medical expertise to warn viewers that using Lustra could somehow harm lung health or function. No supporting evidence or testing data was provided to scientifically back such an alarming statement. It does not appear the reviewer holds professional credentials as a cannabis scientist, medical doctor, or toxicology expert based on available background information. The sweeping assertions made regarding consumer lung health and safety ramifications necessitate substantive domain expertise to ethically disseminate to broad audiences. In the absence of visible qualifications substantiating such guidance, the statements come across as highly speculative and irresponsible..

This sort of vague, unsubstantiated scare tactic around wellness ramifications appears highly irresponsible and unethical. The reviewer meanwhile failed to properly disclose that the same Oasis Cannabis outlet carrying this maligned affordable Lustra brand simultaneously offers many of the glowingly promoted competitor products at significantly lower prices.

This omission further exposes the inherent bias against Oasis Cannabis itself on behalf of unspecified industry allies rather than fair treatment of brands on their merits. When platform access reaches wide audiences, integrity and transparency matter more than ever. This “review” displayed neither in our assessment.

Oasis Cannabis stands ready to furnish lab testing documentation validating our quality assurance practices and the safety of Lustra product materials to any apprehensive prospective purchaser upon request. Please reach out with any concerns so we may clarify directly. We serve customer wellbeing ahead of reviewer friendships. Our medical cannabis mission at Oasis aims to heal, not harm. This review presented a distorted caricature of our sincerely held values.